Investigational Site Number : 3920020

Nagoya, Aichi-ken 457-8511

1 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes — Recruiting now
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed